• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

查耳酮类化合物在抗利什曼病方面的化疗潜力:综述。

The chemotherapeutic potential of chalcones against leishmaniases: a review.

机构信息

Department of Chemistry, Ahmadu Bello University, Zaria, Nigeria.

Department of Biochemistry, Umaru Musa Yar'adua University, Katsina, Nigeria.

出版信息

Int J Antimicrob Agents. 2018 Mar;51(3):311-318. doi: 10.1016/j.ijantimicag.2017.06.010. Epub 2017 Jun 28.

DOI:10.1016/j.ijantimicag.2017.06.010
PMID:28668673
Abstract

Leishmaniases are endemic diseases in tropical and sub-tropical regions of the world and are considered by the World Health Organization (WHO) to be among the six most important neglected tropical diseases. The current therapeutic arsenal against the disease is associated with a series of chemotherapeutic setbacks. However, since the early 1990s, naturally occurring chalcones with promising antileishmanial effects have been reported, and several other synthetic chalcones and chalcone-hybrid molecules have been confirmed to possess potent activity against various Leishmania species. This paper is a comprehensive review covering the antileishmanial activity of 34 naturally occurring chalcones, 224 synthetic/semisynthetic chalcones and 54 chalcone-hybrid molecules. Several chalcones in the synthetic/semisynthetic category had IC values < 5 µM, with very good selectivity against parasites, and the structure-activity relationships as well as the proposed mechanism of action are discussed. We identified knowledge-gaps with the hope of providing future direction for the discovery of novel antileishmanial drugs from chalcones.

摘要

利什曼病是世界热带和亚热带地区的地方病,被世界卫生组织(WHO)认为是六种最重要的被忽视热带病之一。目前针对该疾病的治疗方法与一系列化疗失败有关。然而,自 20 世纪 90 年代初以来,已经报道了具有有前途抗利什曼原虫作用的天然存在的查耳酮,并且已经证实几种其他合成查耳酮和查耳酮杂合分子对各种利什曼原虫具有强大的活性。本文综述了 34 种天然查耳酮、224 种合成/半合成查耳酮和 54 种查耳酮杂合分子的抗利什曼原虫活性。在合成/半合成类别中,有几种查耳酮的 IC 值<5 μM,对寄生虫具有很好的选择性,并且讨论了构效关系以及提出的作用机制。我们确定了知识空白,希望为从查耳酮中发现新型抗利什曼原虫药物提供未来的方向。

相似文献

1
The chemotherapeutic potential of chalcones against leishmaniases: a review.查耳酮类化合物在抗利什曼病方面的化疗潜力:综述。
Int J Antimicrob Agents. 2018 Mar;51(3):311-318. doi: 10.1016/j.ijantimicag.2017.06.010. Epub 2017 Jun 28.
2
Chemotherapy of leishmaniasis part-VIII: synthesis and bioevaluation of novel chalcones.利什曼病的化疗 第八部分:新型查耳酮的合成与生物评价
Eur J Med Chem. 2008 Nov;43(11):2473-8. doi: 10.1016/j.ejmech.2007.12.014. Epub 2007 Dec 27.
3
Molecular Targets for Chalcones in Antileishmanial Drug Discovery.查耳酮类化合物在抗利什曼原虫药物发现中的分子靶标。
Mini Rev Med Chem. 2023;23(14):1414-1434. doi: 10.2174/1389557523666230127125058.
4
The 2',4'-dihydroxychalcone could be explored to develop new inhibitors against the glycerol-3-phosphate dehydrogenase from Leishmania species.2',4'-二羟基查耳酮可用于开发针对利什曼原虫属甘油-3-磷酸脱氢酶的新型抑制剂。
Bioorg Med Chem Lett. 2015 Sep 1;25(17):3564-8. doi: 10.1016/j.bmcl.2015.06.085. Epub 2015 Jun 30.
5
A comprehensive review of chalcone derivatives as antileishmanial agents.查尔酮衍生物作为抗利什曼原虫药物的综合综述。
Eur J Med Chem. 2018 Apr 25;150:920-929. doi: 10.1016/j.ejmech.2018.03.047. Epub 2018 Mar 22.
6
Broad Spectrum and Safety of Oral Treatment with a Promising Nitrosylated Chalcone in Murine Leishmaniasis.口服具有硝基亚砜结构的查尔酮衍生物治疗小鼠利什曼病的广谱性和安全性研究
Antimicrob Agents Chemother. 2018 Sep 24;62(10). doi: 10.1128/AAC.00792-18. Print 2018 Oct.
7
In vitro leishmanicidal activity of naturally occurring chalcones.天然查耳酮的体外抗利什曼原虫活性。
Phytother Res. 2001 Mar;15(2):148-52. doi: 10.1002/ptr.701.
8
Identification of chalcone-based antileishmanial agents targeting trypanothione reductase.鉴定针对硫氧还蛋白还原酶的基于查尔酮的抗利什曼原虫药物。
Eur J Med Chem. 2018 May 25;152:527-541. doi: 10.1016/j.ejmech.2018.04.057. Epub 2018 May 2.
9
Synthesis and evaluation of hybrid sulfonamide-chalcones with potential antileishmanial activity.具有潜在抗利什曼原虫活性的磺酰胺-查耳酮杂合物的合成与评价
Arch Pharm (Weinheim). 2024 Mar;357(3):e2300440. doi: 10.1002/ardp.202300440. Epub 2023 Dec 4.
10
Plants as Antileishmanial Agents: Current Scenario.植物作为抗利什曼原虫药物:现状。
Phytother Res. 2016 Dec;30(12):1905-1925. doi: 10.1002/ptr.5710. Epub 2016 Oct 5.

引用本文的文献

1
Nanocrystallization Effectively Improves the Oral Efficacy of an Antileishmanial Chalcone.纳米晶化有效提高抗利什曼原虫查耳酮的口服疗效。
Pharmaceutics. 2025 Mar 21;17(4):399. doi: 10.3390/pharmaceutics17040399.
2
A Virtual Screening Approach to Evaluate the Multitarget Potential of a Chalcone Library with Binding Properties to Oligopeptidase B and Cysteine Proteinase B from .一种虚拟筛选方法,用于评估查耳酮文库对来自……的寡肽酶B和半胱氨酸蛋白酶B具有结合特性的多靶点潜力。
Int J Mol Sci. 2025 Feb 26;26(5):2025. doi: 10.3390/ijms26052025.
3
Synthesis, fungal biotransformation, and evaluation of the antimicrobial potential of chalcones with a chlorine atom.
氯原子查尔酮的合成、真菌生物转化及抗菌活性评价。
Sci Rep. 2024 Jul 1;14(1):15050. doi: 10.1038/s41598-024-65054-9.
4
(2)-2-(3,4-Di-meth-oxy-benzyl-idene)-3,4-di-hydro-naphthalen-1(2)-one.(2)-2-(3,4-二甲氧基亚苄基)-3,4-二氢萘-1(2)-酮
IUCrdata. 2021 Mar 26;6(Pt 3):x210309. doi: 10.1107/S2414314621003096. eCollection 2021 Mar.
5
Chalcones identify cTXNPx as a potential antileishmanial drug target.查耳酮将 cTXNPx 鉴定为一种潜在的抗利什曼原虫药物靶点。
PLoS Negl Trop Dis. 2021 Nov 15;15(11):e0009951. doi: 10.1371/journal.pntd.0009951. eCollection 2021 Nov.
6
2-Hydroxychalcone as a Potent Compound and Photosensitizer Against Dermatophyte Biofilms.2-羟基查耳酮作为一种抗皮肤癣菌生物膜的强效化合物和光敏剂
Front Cell Infect Microbiol. 2021 May 13;11:679470. doi: 10.3389/fcimb.2021.679470. eCollection 2021.
7
An overview of the treatment of cutaneous leishmaniasis.皮肤利什曼病的治疗概述。
Fac Rev. 2020 Dec 22;9:28. doi: 10.12703/r/9-28. eCollection 2020.
8
Pharmacological Properties of Chalcones: A Review of Preclinical Including Molecular Mechanisms and Clinical Evidence.查耳酮的药理特性:临床前研究综述,包括分子机制和临床证据
Front Pharmacol. 2021 Jan 18;11:592654. doi: 10.3389/fphar.2020.592654. eCollection 2020.
9
Identification of Chalcone Derivatives as Inhibitors of Arginase and Promising Antileishmanial Agents.查尔酮衍生物作为精氨酸酶抑制剂和有前景的抗利什曼原虫药物的鉴定。
Front Chem. 2021 Jan 14;8:624678. doi: 10.3389/fchem.2020.624678. eCollection 2020.
10
Chemotherapy for human schistosomiasis: how far have we come? What's new? Where do we go from here?人类血吸虫病的化疗:我们已经取得了哪些进展?有什么新进展?我们从这里将走向何方?
RSC Med Chem. 2020 Apr 6;11(4):455-490. doi: 10.1039/d0md00062k. eCollection 2020 Apr 1.